ACAD
Acadia Pharmaceuticals IncCompany with tickers: ACAD
CIK
1070494
CUSIP
004225108
Shares Outstanding
171,235,870
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $268,062,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | — | ||||
| Research & Development | $76,868,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Operating Income | $-4,616,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Net Income | $3,637,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| EPS (Basic) | $0.02 | USD/shares | 2026-03-31 | 10-Q | 2026-05-07 |
| EPS (Diluted) | $0.02 | USD/shares | 2026-03-31 | 10-Q | 2026-05-07 |